申请人:AbbVie Inc.
公开号:US20130172334A1
公开(公告)日:2013-07-04
Disclosed herein are compounds of formula (I):
or pharmaceutically acceptable salts thereof, wherein X
1
, L, R
x
, R
y
, G, Z, A, m, n, and p are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also disclosed.
本文公开了公式(I)的化合物:或其药学上可接受的盐,其中X1,L,Rx,Ry,G,Z,A,m,n和p如规范中定义。还公开了包含这些化合物的组合物以及使用这些化合物和组合物治疗疾病和疾病的方法。